EUVIMEDEUVIMED entdecken
Crossref

Protease-activated Receptor 1 Targeted Screening of Potential Antithrombotic Compounds with Hemostatic Activity from Polygonum Amplexicaule D. Don var. Sinense Forb

Shiyi Huang, Xiangchang He, Jie Dai, Ting Zou, Hongqing Zhao, Guangming Xu iD

Cardiovascular Drugs and Therapy · 2025

DOI: 10.1007/s10557-025-07797-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Drugs and Therapy, 2025. Verfasst von Shiyi Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hunan University of Chinese Medicine, 300 Bachelors Road, Yuelu District, Changsha Hunan, 410208, China. Hauptthemen laut MEDLINE: Polygonum, Fibrinolytic Agents, Receptor, PAR-1, Platelet Aggregation Inhibitors. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Hunan Provincial Natural Science Foundation Project, Hunan Provincial Scientific Research Project of Traditional Chinese Medicine, Scientific Research Fund of Hunan Provincial Education Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: this study aims to screen Protease-activated receptor 1 (PAR1) inhibitory active components with low bleeding side effects from anti-thrombin phytochemicals in Polygonum amplexicaule D. Don var. sinense Forb (PAF) to achieve multi-pathway antithrombosis without disrupting platelet hemostasis. METHODS: Docking simulation and platelet aggregation test were used to investigate interaction of PAR1-ligands to screen out anti-PAR1 active ingredients. FeCl3-induced carotid artery (CA) thrombosis and inferior vena cava (IVC)-ligated thrombosis model were constructed to collect thrombi to weigh. Histopathological analysis, coagulation function, and hemorheological indicator detection of administered rats were conducted to analyze antithrombotic effectiveness and mechanism of these compounds, which were injected in tail veins of mice to evaluate bleeding side effects. RESULTS: Three promising ligands (epigallocatechin gallate, homoorientin, and myricetin) with strong affinity of PAR1 were selected from PAF. Epigallocatechin gallate and homoorientin showed antithrombotic effects with decreased bleeding tendency based on activity validation, suggesting that they may be prospective and effective candidate compounds of PAR1 antagonists. CONCLUSION: the integrative strategy applied to these active components allowed to rapidly discover compounds with reducing bleeding side effects during thrombus treatment, providing valuable references for precisely targeted therapy and mechanism exploration of medicinal plants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolygonumFibrinolytic AgentsReceptor, PAR-1Platelet Aggregation InhibitorsThrombosisPlant ExtractsHemostaticsAnimalsMalePlatelet AggregationMolecular Docking SimulationDisease Models, AnimalRats, Sprague-DawleyMiceHumansHemorrhageRats

Stichwörter der Autor:innen

Polygonum Amplexicaule D. don var. Sinense forbMolecular dockingPlateletProtease-activated receptor 1

Substanzen

Fibrinolytic AgentsReceptor, PAR-1Platelet Aggregation InhibitorsPlant ExtractsHemostatics

Autor:innen und Institutionen

  • School of Pharmacy, Hunan University of Chinese Medicine, 300 Bachelors Road, Yuelu District, Changsha Hunan, 410208, China.
  • Science & Technology Innovation Center, Hunan University of Chinese Medicine, 300 Bachelors Road, Yuelu District, Changsha Hunan, 410208, China. zhaohongq@hnucm.edu.cn.
  • School of Pharmacy, Hunan University of Chinese Medicine, 300 Bachelors Road, Yuelu District, Changsha Hunan, 410208, China. 1052262329@qq.com.

ORCID-Profile: Guangming Xu

Förderung

  • Hunan Provincial Natural Science Foundation Project
  • Hunan Provincial Scientific Research Project of Traditional Chinese Medicine
  • Scientific Research Fund of Hunan Provincial Education Department

Zitieren

APA

Huang, S., He, X., Dai, J., Zou, T., Zhao, H., & Xu, G. (2025). Protease-activated Receptor 1 Targeted Screening of Potential Antithrombotic Compounds with Hemostatic Activity from Polygonum Amplexicaule D. Don var. Sinense Forb. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-025-07797-9

Vancouver

Huang S, He X, Dai J, Zou T, Zhao H, Xu G. Protease-activated Receptor 1 Targeted Screening of Potential Antithrombotic Compounds with Hemostatic Activity from Polygonum Amplexicaule D. Don var. Sinense Forb. Cardiovascular Drugs and Therapy. 2025. doi:10.1007/s10557-025-07797-9

BibTeX
@article{Huang2025,
  author = {Huang, Shiyi and He, Xiangchang and Dai, Jie and Zou, Ting and Zhao, Hongqing and Xu, Guangming},
  title = {Protease-activated Receptor 1 Targeted Screening of Potential Antithrombotic Compounds with Hemostatic Activity from Polygonum Amplexicaule D. Don var. Sinense Forb},
  journal = {Cardiovascular Drugs and Therapy},
  year = {2025},
  doi = {10.1007/s10557-025-07797-9}
}
Kostenlos starten →